The Worlds #1 Renewable Energy Network for News & Information
Sign In
or
Register
Sections
Home
Solar
Wind
Geothermal
Bio
Hydro
Careers
Companies
Webcasts
White Papers
Magazines
Awards
Account
Sign In
Register
Search
REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
PACIRA
(NQ:
PCRX
)
28.44
USD
-1.00 (-3.40%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 20, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
29.70
Bid (Size)
28.45 (100)
Ask (Size)
28.46 (7300)
Prev. Close
29.44
Today's Range
27.72 - 30.00
52wk Range
9.810 - 30.94
Shares Outstanding
33,047,004
Dividend Yield
N/A
Top News
More News
Thursday's ETF with Unusual Volume: XPH
May 09, 2013
The SPDR S&P Pharmaceuticals ETF (XPH) is seeing unusually high volume in afternoon trading Thursday, with over 274,000 shares traded versus three month average volume of about 26,000. Shares of XPH...
Read More
category
ETFs
from
ETF Channel
Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 08, 2013
from
Business Wire News Releases
More News
Read More
Pacira Pharmaceuticals, Inc. Reports $10.4 Million in First Quarter EXPAREL Revenue and Full First Quarter 2013 Financial Results
May 08, 2013
from
Business Wire News Releases
Two New Studies Support Use of EXPAREL via Infiltration Into the Transversus Abdominis Plane for Postsurgical Pain Control
May 06, 2013
category
PCRX
,
Benzinga
,
News
from
Latest Articles from Benzinga.com
Two New Studies Support Use of EXPAREL via Infiltration Into the Transversus Abdominis Plane for Postsurgical Pain Control
May 06, 2013
from
Business Wire News Releases
Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
May 01, 2013
from
Business Wire News Releases
New Published Analysis Finds Opioid-Related Adverse Events Increase Hospital Stays, Costs of Care and Risks of Readmission and Mortality
April 25, 2013
from
Business Wire News Releases
New Data Support the Benefits of EXPAREL for Postsurgical Analgesia Following Aesthetic Plastic Surgery Procedures
April 12, 2013
from
Business Wire News Releases
Pacira Pharmaceuticals, Inc. [PCRX] to Ring The NASDAQ Stock Market Closing Bell
April 05, 2013
from
GlobeNewswire News Releases
Pacira Pharmaceuticals, Inc. to Close The NASDAQ Stock Market on April 8, 2013
April 05, 2013
from
Business Wire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here